You are here

Merkc

FDA grants priority review for Daiichi Sankyo-Merck’s lung cancer therapy

Pharmaceutical Business Review

Wed, 12/27/23 - 11:00 pm

patritumab deruxtecan

non-small cell lung cancer

Merck ends trial of Intercell's MRSA vaccine

Yahoo/AP

Wed, 06/8/11 - 08:29 am